Surgical site infections among high-risk patients in clean-contaminated head and neck reconstructive surgery: Concordance with preoperative oral flora

Annals of Plastic Surgery

Volumn 71, Issue SUPPL.1, 2013, Pages

  Yang, Ching Hsiang ^a   Chew, Khong Yik ^b   Solomkin, Joseph S ^c   Lin, Pao Yuan ^a   Chiang, Yuan Cheng ^a   Kuo, Yur Ren ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

index; free flap; head and neck oncological surgery; perioperative antibiotics; surgical site infection

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; GENTAMICIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; FEMALE; FREE TISSUE GRAFT; HEAD AND NECK TUMOR; HUMAN; HYPOPHARYNX TUMOR; MALE; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MOUTH; PLASTIC SURGERY; PREOPERATIVE PERIOD; RISK ASSESSMENT; SALIVA; SURGICAL INFECTION; YOUNG ADULT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARCINOMA, SQUAMOUS CELL; CLINDAMYCIN; FEMALE; FREE TISSUE FLAPS; GENTAMICINS; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH; PREOPERATIVE PERIOD; RECONSTRUCTIVE SURGICAL PROCEDURES; RISK ASSESSMENT; SALIVA; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 84889879093     PISSN: 01487043     EISSN: 15363708     Source Type: Journal    
DOI: 10.1097/SAP.0000000000000046     Document Type: Article

References (54)

1. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27:97-132; quiz 133-134; discussion 196.
2. Liljemark WF, Bloomquist C. Human oral microbial ecology and dental caries and periodontal diseases. Crit Rev Oral Biol Med. 1996;7:180-198.
3. Mager DL, Ximenez-Fyvie LA, Haffajee AD, et al. Distribution of selected bacterial species on intraoral surfaces. J Clin Periodontol. 2003;30:644-654.
4. Jenkinson HF, Lamont RJ. Oral microbial communities in sickness and in health. Trends Microbiol. 2005;13:589-595.
5. Diaz PI, Dupuy AK, Abusleme L, et al. Using high throughput sequencing to explore the biodiversity in oral bacterial communities. Mol Oral Microbiol. 2012;27:182-201.
6. Seagle MB, Duberstein LE, Gross CW, et al. Efficacy of cefazolin as a prophylactic antibiotic in head and neck surgery. Otolaryngology. 1978;86: 568-572.
7. Johnson JT, Myers EN, Thearle PB, et al. Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope. 1984;94:46-51.
8. Johnson JT, Yu VL, Myers EN, et al. Efficacy of two third-generation cephalosporins in prophylaxis for head and neck surgery. Arch Otolaryngol. 1984;110:224-227.
9. Johnson JT, Schuller DE, Silver F, et al. Antibiotic prophylaxis in high-risk head and neck surgery: One-day vs. five-day therapy. Otolaryngol Head Neck Surg. 1986;95:554-557.
10. Johnson JT, Wagner RL, Schuller DE, et al. Prophylactic antibiotics for head and neck surgery with flap reconstruction. Arch Otolaryngol Head Neck Surg. 1992;118:488-490.
11. Velanovich V. A meta-Analysis of prophylactic antibiotics in head and neck surgery. Plast Reconstr Surg. 1991;87:429-434.
12. Phan M, Auwera PVd, Andry G, et al. Antimicrobial prophylaxis for major head and neck surgery in cancer patients: Sulbactam-Ampicillin versus clindamycin-Amikacin. Antimicrob Agents Chemother. 1992;36:2014-2019.
13. Rodrigo JP, Alvarez JC, Gómez JR, et al. Comparison of three prophylactic antibiotic regimens in clean-contaminated head and neck surgery. Head Neck. 1997;19:188-193.
14. Skitarelic N, Morovic M, Manestar D. Antibiotic prophylaxis in cleancontaminated head and neck oncological surgery. J Craniomaxillofac Surg. 2007;35:15-20.
15. Huang RY, Sercarz JA, Smith J, et al. Effect of salivary fistulas on free flap failure: A laboratory and clinical investigation. Laryngoscope. 2005;115: 517-521.
16. Frederick JW, Sweeny L, Carroll WR, et al. Outcomes in head and neck reconstruction by surgical site and donor site. Laryngoscope. 2013;123: 1612-1617.
17. McMahon JD, Maciver C, Smith M, et al. Postoperative complications after major head and neck surgery with free flap repair-prevalence, patterns, and determinants: A prospective cohort study. Br J Oral Maxillofac Surg. 2013.
18. Benatar MJ, Dassonville O, Chamorey E, et al. Impact of preoperative radiotherapy on head and neck free flap reconstruction: A report on 429 cases. J Plast Reconstr Aesthet Surg. 2013;66:478-482.
19. Vandersteen C, Dassonville O, Chamorey E, et al. Impact of patient comorbidities on head and neck microvascular reconstruction. A report on 423 cases. Eur Arch Otorhinolaryngol. 2013;270:1741-1746.
20. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250-278.
21. Danilla S, Andrades P, Gomez ME, et al. Concordance between qualitative and quantitative cultures in burned patients. Analysis of 2886 cultures. Burns. 2005;31:967-971.
22. Cyr L, Francis K. Measures of clinical agreement for nominal and categorical data: The kappa coefficient. Comput Biol Med. 1992;22:239-246.
23. Rigby AS. Statistical methods in epidemiology. v. Towards an understanding of the kappa coefficient. Disabil Rehabil. 2000;22:339-344.
24. Cohen J. Weighted kappa: Nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213-220.
25. Kwiecien R, Kopp-Schneider A, Blettner M. Concordance analysis: Part 16 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2011;108:515-521.
26. Chen YL, Tsai SH, Hsu KC, et al. Primary sternal osteomyelitis due to Peptostreptococcus anaerobius. Infection. 2012;40:195-197.
27. Graninger W, Ragette R. Nosocomial bacteremia due to Enterococcus faecalis without endocarditis. Clin Infect Dis. 1992;15:49-57.
28. Odeh M, Oliven A, Potasman I, et al. Pyomyositis of the thigh due to Prevotella melaninogenica. Infection. 2000;28:49-50.
29. Sedgley CM, Samaranayake LP. Antimicrobial susceptibility of oral isolates of Enterobacter cloacae and Klebsiella pneumoniae from a southern Chinese population. Oral Microbiol Immunol. 1998;13:315-321.
30. Bland KI, Palin WE, von Fraunhofer JA, et al. Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann Surg. 1984;199:782-790.
31. Devalia HL, Mansfield L. Radiotherapy and wound healing. Int Wound J. 2008;5:40-44.
32. Gieringer M, Gosepath J, Naim R. Radiotherapy and wound healing: Principles, management and prospects (review). Oncol Rep. 2011;26:299-307.
33. Johnson JT, Yu VL, Myers EN, et al. An assessment of the need for gramnegative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis. 1987;55:331-333.
34. Johnson JT, Yu VL. Role of anaerobic bacteria in postoperative wound infections following oncologic surgery of the head and neck. Ann Otol Rhinol Laryngol Suppl. 1991;154:46-48.
35. Johnson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med. 1969;281:1137-1140.
36. Sonalika WG, Amsavardani Tayaar S, Bhat KG, et al. Oral microbial carriage in oral squamous cell carcinoma patients at the time of diagnosis and during radiotherapyVa comparative study. Oral Oncol. 2012;48:881-886.
37. Shao H, Demuth DR. Quorum sensing regulation of biofilm growth and gene expression by oral bacteria and periodontal pathogens. Periodontol 2000. 2010;52:53-67.
38. Guo SE, Huang TJ, Huang JC, et al. Alcohol, betel-nut and cigarette consumption are negatively associated with health promoting behaviors in Taiwan: A cross-sectional study. BMC Public Health. 2013;13:257.
39. Ko YC, Huang YL, Lee CH, et al. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 1995;24:450-453.
40. Hooper SJ, Crean SJ, Fardy MJ, et al. A molecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol. 2007;56: 1651-1659.
41. Becker GD. Identification and management of the patient at high risk for wound infection. Head Neck Surg. 1986;8:205-210.
42. Lofmark S, Jernberg C, Jansson JK, et al. Clindamycin-induced enrichment and long-Term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother. 2006;58:1160-1167.
43. Salyers AA, Amabile-Cuevas CF. Why are antibiotic resistance genes so resistant to eliminatioñ Antimicrob Agents Chemother. 1997;41:2321-2325.
44. Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192:5002-5017.
45. Robbins KT, Favrot S, Hanna D, et al. Risk of wound infection in patients with head and neck cancer. Head Neck. 1990;12:143-148.
46. Johnson JT, Yu VL. Role of aerobic gram-negative rods, anaerobes, and fungi in wound infection after head and neck surgery: Implications for antibiotic prophylaxis. Head Neck. 1989;11:27-29.
47. Weber RS, Raad I, Frankenthaler R, et al. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverage. Arch Otolaryngol Head Neck Surg. 1992;118:1159-1163.
48. Russell MD, Goldberg AN. What is the evidence for use of antibiotic prophylaxis in clean-contaminated head and neck surgery? Laryngoscope. 2012;122:945-946.
49. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70: 195-283.
50. Tally FP, Snydman DR, Gorbach SL, et al. Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. J Infect Dis. 1979;139:83-88.
51. Rubin J, Johnson JT, Wagner RL, et al. Bacteriologic analysis of wound infection following major head and neck surgery. Arch Otolaryngol Head Neck Surg. 1988;114:969-972.
52. Begg EJ, Barclay ML. AminoglycosidesV50 years on. Br J Clin Pharmacol. 1995;39:597-603.
53. Barclay ML, Begg EJ, Hickling KG. What is the evidence for once-daily aminoglycoside therapy? Clin Pharmacokinet. 1994;27:32-48.
54. Barclay ML, Kirkpatrick CM, Begg EJ. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored? Clin Pharmacokinet. 1999;36:89-98.